News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
289,387 Results
Type
Article (16441)
Company Profile (283)
Press Release (272663)
Section
Business (82760)
Career Advice (295)
Deals (14034)
Drug Delivery (43)
Drug Development (51511)
Employer Resources (58)
FDA (6042)
Job Trends (5570)
News (150299)
Policy (10987)
Tag
Academia (1017)
Alliances (22306)
Alzheimer's disease (866)
Antibody-drug conjugate (ADC) (79)
Approvals (6040)
Artificial intelligence (105)
Bankruptcy (116)
Best Places to Work (4892)
Biotechnology (233)
Breast cancer (140)
Cancer (1180)
Cardiovascular disease (99)
Career advice (252)
CAR-T (100)
Cell therapy (292)
Clinical research (41379)
Collaboration (465)
Compensation (189)
COVID-19 (1189)
C-suite (123)
Cystic fibrosis (76)
Data (1213)
Diabetes (120)
Diagnostics (1514)
Earnings (30788)
Events (49066)
Executive appointments (371)
FDA (6585)
Funding (438)
Gene editing (79)
Gene therapy (213)
GLP-1 (370)
Government (1356)
Healthcare (7208)
Infectious disease (1248)
Inflammatory bowel disease (107)
IPO (7542)
Job creations (984)
Job search strategy (228)
Layoffs (210)
Legal (1567)
Lung cancer (166)
Manufacturing (116)
Medical device (2937)
Medtech (2938)
Mergers & acquisitions (6741)
Metabolic disorders (351)
Neuroscience (1196)
NextGen: Class of 2025 (2273)
Non-profit (1102)
Northern California (1400)
Obesity (183)
Opinion (117)
Parkinson's disease (91)
Patents (95)
People (26093)
Phase I (14511)
Phase II (19180)
Phase III (12259)
Pipeline (556)
Postmarket research (901)
Preclinical (6085)
Radiopharmaceuticals (212)
Rare diseases (255)
Real estate (1575)
Regulatory (9005)
Research institute (1032)
Series A (82)
Southern California (1257)
Startups (2015)
United States (11184)
Vaccines (251)
Weight loss (107)
Date
Today (7)
Last 7 days (483)
Last 30 days (1562)
Last 365 days (21010)
2025 (3216)
2024 (21268)
2023 (23218)
2022 (31896)
2021 (32631)
2020 (26737)
2019 (17895)
2018 (13051)
2017 (14377)
2016 (12565)
2015 (15033)
2014 (10888)
2013 (7970)
2012 (8031)
2011 (8159)
2010 (7855)
Location
Africa (195)
Asia (18136)
Australia (3044)
California (3206)
Canada (1027)
China (292)
Colorado (121)
Connecticut (135)
Delaware (78)
Europe (39449)
Florida (383)
Georgia (98)
Illinois (208)
Indiana (80)
Maryland (419)
Massachusetts (2548)
Minnesota (127)
New Jersey (812)
New York (892)
North Carolina (495)
Northern California (1400)
Ohio (101)
Pennsylvania (608)
South America (256)
Southern California (1257)
Texas (364)
Washington State (304)
289,387 Results for "rise therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rise Therapeutics Receives FDA IND Clearance to Initiate Clinical Testing of R-5780 in Cancer
January 14, 2025
·
2 min read
Press Releases
Dose Escalation Completed for Rise Therapeutics’ R-3750 and R-2487 Clinical Trials
January 6, 2025
·
2 min read
Deals
Pharmas Turn to Licensing Deals as Risky Science Rises
Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the biotech ecosystem? Experts weigh in.
January 8, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
PESG Report: Silexion Therapeutics’ Systemic Delivery Breakthrough Positions Company as Rising Star in The Multi-Billion Dollar Precision Oncology Market
January 29, 2025
·
3 min read
China
The Rise of China Innovation in the Time of Trump
With incoming president Donald Trump threatening a trade war with China, experts told
BioSpace
that the new administration will likely understand why medicines should be treated differently.
January 16, 2025
·
4 min read
·
Annalee Armstrong
Collaboration
Cassava’s Stock Rises After Licensing Seizure Rights for Embattled Drug Simufilam
The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its Alzheimer’s disease drug simufilam.
February 28, 2025
·
2 min read
·
Tristan Manalac
Infectious disease
AbbVie Gets FDA Approval for New Antibiotic in the Face of Rising Resistance
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in partnership with Pfizer. AbbVie acquired its share of the asset as part of its $63 billion buyout of Allergan.
February 10, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Vizient Forecasts a 3.84% Rise in Pharmacy Spending
January 28, 2025
·
5 min read
Press Releases
Myocarditis Market Size to Reach USD 2,391.5 Million by 2035, Impelled by Rising Incidence of Myocarditis
February 19, 2025
·
7 min read
Press Releases
New Funding Secured to Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
October 24, 2024
·
2 min read
1 of 28,939
Next
